Swann P F, Coe A M, Mace R
Carcinogenesis. 1984 Oct;5(10):1337-43. doi: 10.1093/carcin/5.10.1337.
Alcohol consumption is associated with an increase in human cancer, notably of the oesophagus. We have found that ethanol will alter profoundly the distribution of two carcinogenic nitrosamines in the rat. Small oral doses of dimethylnitrosamine (NDMA) are absorbed from the portal blood as it passes through the liver, and do not reach the extrahepatic organs. Ethanol, equivalent to a man drinking 1 pint (0.5 l) of beer, prevents this first pass clearance in the rat and exposes sensitive extrahepatic organs to this carcinogen. As a consequence the alkylation of kidney DNA by 35 micrograms NDMA/kg body weight was increased 4.6-fold by concurrent administration of 240 mg ethanol/kg, and smaller doses of [14C]-NDMA produced detectable alkylation of kidney DNA only if the rats were given ethanol. Measurement of metabolism of NDMA by liver slices confirmed that this action of ethanol is the result of inhibition by ethanol of NDMA metabolism in liver (Ki = 0.5 mM). Comparison of urinary excretion in man and rat suggests that ethanol also inhibits first pass clearance of NDMA in man. There was no complete first pass clearance of diethylnitrosamine (NDEA), but while ethylation of kidney DNA was decreased by ethanol, that of oesophageal DNA was increased between 1.8- and 4.6-fold. Measurement of the metabolism of NDEA to CO2 by liver slices, kidney slices, and oesophageal epithelium suggest that the changes in alkylation of kidney and oesophageal DNA are the result of selective inhibition of NDEA metabolism in liver and kidney. The ethylation of oesophageal DNA was greater relative to liver after a small dose than after a large dose possibly because of the low Km of the oesophageal metabolic activating system relative to that in liver and kidney. These results explain experiments showing that concurrent administration of ethanol increases the carcinogenicity and alters the organs affected by these nitrosamines. It is tentatively proposed that the effect of ethanol on human cancer incidence is mediated through similar influences on the metabolism and disposition of the nitrosamines to which man is exposed.
饮酒与人类癌症的增加有关,尤其是食管癌。我们发现乙醇会深刻改变大鼠体内两种致癌亚硝胺的分布。口服小剂量的二甲基亚硝胺(NDMA)在门静脉血通过肝脏时会被吸收,不会到达肝外器官。相当于人饮用1品脱(0.5升)啤酒的乙醇量,会阻止大鼠的首过清除,并使敏感的肝外器官暴露于这种致癌物中。因此,同时给予240毫克乙醇/千克体重时,35微克NDMA/千克体重对肾脏DNA的烷基化作用增加了4.6倍,只有在给大鼠喂食乙醇时,小剂量的[14C]-NDMA才会产生可检测到的肾脏DNA烷基化。肝脏切片对NDMA代谢的测量证实,乙醇的这种作用是由于乙醇抑制了肝脏中NDMA的代谢(Ki = 0.5 mM)。人与大鼠尿液排泄的比较表明,乙醇也会抑制人类体内NDMA的首过清除。二乙基亚硝胺(NDEA)没有完全的首过清除,但虽然乙醇会降低肾脏DNA的乙基化,但食管DNA的乙基化会增加1.8至4.6倍。肝脏切片、肾脏切片和食管上皮对NDEA代谢为二氧化碳的测量表明,肾脏和食管DNA烷基化的变化是肝脏和肾脏中NDEA代谢受到选择性抑制的结果。小剂量后食管DNA的乙基化相对于肝脏比大剂量后更大,这可能是因为食管代谢激活系统的Km相对于肝脏和肾脏较低。这些结果解释了实验表明同时给予乙醇会增加致癌性并改变这些亚硝胺所影响的器官。初步提出,乙醇对人类癌症发病率的影响是通过对人类接触的亚硝胺的代谢和处置产生类似影响来介导的。